GlaxoSmithKline
Do more, feel better, live longer
Research & development
From molecules to medicines
Our scientists are working hard to discover new ways of treating and preventing diseases.
Our success depends on a vibrant and productive R&D function. To this end, we have established an innovative R&D structure that encourages creativity and facilitates the accelerated discovery and development of new medicines.
External collaborations
We also build collaborations and links with other research groups, biotechnology companies and academic institutions to help develop transformative scientific concepts.
R&D organisation
We have a large and promising development pipeline, due in the main to our innovative R&D organisation, which concentrates research in key areas through our Centres of Excellence of Drug Discovery (CEDDs).
Our CEDDs are focused on five therapeutic areas:
- Infectious disease
- Metabolic pathways
- Neurosciences
- Respiratory
- Immunoinflammation
R&D innovation
Our Centre of Excellence for External Drug Discovery (CEEDD) is open for innovation.
Call for proposals for HIV Collaborative Investigator Research Award Program (HIV CIRA)
Download the HIV CIRA flyer (PDF 1MB)
